ANTIPLATELET ACTIVITY OF ORIGINAL CLOPIDOGREL AND ITS GENERIC: RESULTS OF RANDOMIZED COMPARATIVE CROSS-OVER STUDY

ANTIPLATELET ACTIVITY OF ORIGINAL CLOPIDOGREL AND ITS GENERIC: RESULTS OF RANDOMIZED COMPARATIVE CROSS-OVER STUDY

Show other versions (1)

<p><strong>Objective</strong> — to study therapeutic equivalence (efficacy, safety and tolerability) and hemorheological activity of original clopidogrel and its<br />generic in patients of high cardiovascular risk.</p><p><br /><strong>Materials and me...

Full description

Bibliographic Details
Main Authors:	V. V. Yakusevich, A. S. Petrochenko, V. S. Simonov, N. Yu. Levshin, A. D. Deev
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	clopidogrel equivalence plavix plagril
Online Access:	http://klinitsist.abvpress.ru/index.php/Klin/article/view/87

Similar Items

ANTIPLATELET ACTIVITY OF ORIGINAL CLOPIDOGREL AND ITS GENERIC: RESULTS OF RANDOMIZED COMPARATIVE CROSS-OVER STUDY
by: V. V. Yakusevich, et al.
Published: (2014-07-01)

COMPARISON OF THE ORIGINAL (PLAVIx) AND GENERIC (CLAPITAx) CLOPIDOGREL ON PLATELET AGGREGATION: ObSERVATIONAL STUDY
by: A. S. Skotnikov, et al.
Published: (2018-05-01)

THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY
by: V. V. Yakusevich, et al.
Published: (2016-01-01)

Perioperative clopidogrel (Plavix) continuation in shoulder arthroplasty: approach cautiously
by: Thomas H. Rogers, MD, et al.
Published: (2022-05-01)

Chromatographic determination of clopidogrel bisulfate; detection and quantification of counterfeit Plavix® tablets
by: Mona E. ElTantawy, et al.
Published: (2014-06-01)

THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY
by: V. V. Yakusevich, et al.
Published: (2016-01-01)

Patient-specific choice of an antiplatelet drug for long-term therapy of coronary heart disease: rationale and implementationL
by: NA Mazur
Published: (2014-12-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
by: Daniele Jones, et al.
Published: (2024-01-01)

Effect of original and generic clopidogrel on prognosis in relation to different gene polymorphisms
by: D F Mesitskaia, et al.
Published: (2014-09-01)

Acute Respiratory Distress Syndrome Associated With Clopidogrel in a Young Male Patient
by: Stephanie M. Roses, et al.
Published: (2019-03-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

ROLE OF THE ANTIPLATELET DRUGS IN TREATMENT OF STABLE ANGINA: COMMON SENSE AND NON-RESOLVED ISSUES
by: V. V. Yakusevich, et al.
Published: (2015-07-01)

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV
by: Emanuela Marcantoni, PhD, et al.
Published: (2022-11-01)

ASSOCIATION BETWEEN SMOKING AND THE ANTIPLATELET EFFECT OF CLOPIDOGREL
by: K. Yu. Lukianets, et al.
Published: (2020-10-01)

Influence of rabeprazole and famotidine on pharmacodynamic profile of dual antiplatelet therapy in clopidogrel-sensitive patients: The randomized, prospective, PROTECT trial
by: Jong-Hwa Ahn, et al.
Published: (2020-04-01)

Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
by: Hyun Goo Kang, et al.
Published: (2021-08-01)

The effectiveness, side effects and acceptability of locally available brand of Clopidogrel (Osvix) as antiplatelet tablet in CABG patients
by: Behzad Imani, et al.
Published: (2014-07-01)

La era de la farmacogenómica: el ejemplo del clopidogrel Farmacogenomics Era: The Clopidogrel Example
by: Allan Ramos-Esquivel, et al.
Published: (2012-03-01)

ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY?
by: S. J. Martsevich
Published: (2016-01-01)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
by: Jan Kiebist, et al.
Published: (2021-09-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)

Comparative bioavailability of two oral formulations of clopidogrel: Determination of clopidogrel and its carboxylic acid metabolite (SR26334) under fasting and fed conditions in healthy subjects
by: Brvar Nina, et al.
Published: (2014-03-01)

The study of structural-mechanical characteristics of suppositories with clopidogrel
by: Ye. А. Redkina, et al.
Published: (2018-10-01)

Spontaneous atraumatic heparin-induced hemarthrosis in a patient treated for non-ST-elevation myocardial infarction
by: Inderbir Padda, MD, et al.
Published: (2023-04-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Clopidogrel use and smoking cessation result in lower coated-platelet levels after stroke
by: Angelia C. Kirkpatrick, et al.
Published: (2020-02-01)

Influence of methadone on clopidogrel in addicts on methadone maintenance therapy
by: Ferigol Fallah, et al.
Published: (2016-04-01)

In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris
by: Rza Hajizadeh, et al.
Published: (2017-12-01)

Comparative study of specific activity of rectal suppositories with clopidogrel
by: I. L. Kechyn, et al.
Published: (2021-12-01)

The study of excipients’ influence on Clopidogrel releasing from the rectal suppositories
by: Ye. А. Redkina, et al.
Published: (2018-03-01)

Clopidogrel-statin interaction: A missing links
by: Todorović Zoran M., et al.
Published: (2016-01-01)

THE MODERN ASPECTS OF CLOPIDOGREL USE
by: E. N. Dankovtseva, et al.
Published: (2016-01-01)

Evaluation ofAaspirin, Clopidogrel or Their Combination In Hypertensive Patients
by: Fadia Y. Al-hamdani, et al.
Published: (2010-12-01)

Effect of obesity and serum leptin level on clopidogrel resistance
by: Ali Dogan, et al.
Published: (2016-10-01)

Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients
by: In Hwan Lim, et al.
Published: (2022-06-01)

Budget impact analysis of antiplatelet therapy with ticagrelor and clopidogrel in patients with acute coronary syndrome after coronary artery bypass surgery
by: S K Zyryanov, et al.
Published: (2016-09-01)

ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES
by: V. V. Yakusevich
Published: (2015-12-01)

Predictors of premature clopidogrel discontinuation within 30 days of successful coronary artery stenting
by: Çayan Cakir, et al.
Published: (2018-01-01)

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)